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Cold urticaria is one form of urticaria that may be
associated with other forms of physical urticarias.
Frequency is generally estimated at two or three per
100. The triggering effect of cold is found at history
taking in most of the cases. The urticaria is usually
super®cial, and more rarely associated with deep
and/or mucosal urticaria. The diagnosis is based on
history taking and the ice cube test. An exhaustive
search for an etiologic factor is often unfruitful, and
the presence of a cryopathy should lead to a com-
plete work-up. Therapy of cold urticaria may prove
to be dif®cult. In patients with secondary cold urti-
caria, underlying disease must be treated in order to
resolve the skin symptoms. H1-antihistamines can be
used but the clinical responses are highly variable.
Short-time treatment with low concentration cortico-
steroids suppresses the symptoms only partially and
temporarily. In patients who do not respond to pre-
vious treatments, induction of cold tolerance may be
proposed but the procedure is dif®cult to carry out in
daily life over an extended period. Key word: cryo-
globulins. Journal of Investigative Dermatology Symposium
Proceedings 6:141±142, 2001
C
old urticaria (CU) is a distinct clinical entity
characterized by redness, itching, wheals, and edema
on the cold-exposed skin. The lesions can be strictly
limited to the site of contact to cold or can be
generalized with a risk of systemic symptoms such as
headaches, chills, tachycardia, and diarrhea. Oral mucous mem-
branes can also be involved (MoÈller and Henz, 1998). Different
clinical manifestations of CU have been described, including cold-
induced dermographic urticaria, localized CU, cold re¯ex urticaria,
perifollicular CU, cholinergic CU, and autosomal dominant
delayed familial CU (Baxter et al, 1992; Ormerod et al, 1993).
Delayed CU has a latency of 3±24 h after cold exposure and persists
up to 24 h. In systemic familial CU, the rash is maculopapular,
different from classical acute urticaria, and can be triggered by cold
winds. The diagnosis can be ascertained by the ice cube test with
the appearance of a wheal on rewarming. This test may become
negative when CU symptoms have decreased. Ethyl chloride, cold
water on the arm (15 min, 8°C), or cold air can also be tested
(MoÈller and Henz, 1998).
The cause of CU is unknown. Histamine has been suggested to
be the main mediator but other in¯ammatory mediators such as
prostaglandins, proteinases, and kinins are also released during the
reaction (Kaplan et al, 1981). A recent study suggests that histamine
is not central to the pathogenesis of vascular changes in acquired
CU (Keahey and Greaves, 1980). Vasculitis has been demonstrated
in the skin of patients who have been repeatedly challenged by cold
with the presence of IgM, C3, and ®brin in the blood vessel walls
(Ahmed and Moy, 1981).
The frequency of CU varies between 5.2% and 33.8% (MoÈller
and Henz, 1998), with a higher incidence in cold climates. CU can
also be seen in tropical regions. The women/men ratio is 2/1 and
the peak age incidence is between 20 and 30 y. The mean age of
onset is 22 y for idiopathic CU and 49 y for secondary CU (MoÈller
and Henz, 1998).
Idiopathic CU is more frequent than secondary CU
(NeittaanmaÈki, 1985; Wanderer et al, 1986; Henquet et al, 1992;
Husz et al, 1994; Koeppel et al, 1996) (Table I). CU secondary to
serum cryoproteins is rare (1%), whereas CU occurs in only 3% of
people with cryoglobulinemia (NeittaanmaÈki, 1985; Wanderer et al,
1986; Henquet et al, 1992; Husz et al, 1994; Koeppel et al, 1996)
(Table II). CU may precede the presence of cryoglobulins or
myeloma by many years and may disappear after reduction of
cryoglobulins. CU has been described in association with infectious
mononucleosis, hepatitis, measles, HIV, borreliosis, syphilis, and
bacterial infections (Lemanske and Bush, 1982; NeittaanmaÈki,
1985; Wanderer et al, 1986; Henquet et al, 1992; Husz et al, 1994;
Yu et al, 1995; Koeppel et al, 1996) (Table III). The incidence of
atopy seems to be higher than in control groups (MoÈller and Henz,
1998).
Routine laboratory investigations may include serology for
syphilis, borreliosis, HIV, EBV, search for cryoglobulins, cold
agglutinins, cryo®brinogens, and a complete blood cell count.
Treatment consists of avoiding cold exposure (ice cream, cold
beverages, cold water). Suspected drugs should be discontinued. In
patients with secondary CU, underlying disease must be treated in
order to resolve the skin symptoms. MoÈller and Henz (1998) state
that up to 50% of patients respond to a 2-wk treatment with
penicillin or tetracyclin and propose to use such a treatment in each
case. Nonsedating H1-antihistamines can be used but the clinical
responses are highly variable (Villas-Martinez et al, 1992). Doxepin,
a potent H1-blocker, hydroxyzine, and cinnarizine have been
shown to be more effective than placebo (NeittaanmaÈki et al, 1984).
Short-time treatment with low concentration of corticosteroids
partially and only temporarily suppresses the symptoms of CU
(Kobza-Black et al, 1981). Stanazolol may be useful for the rare
forms of familial CU (Ormerod et al, 1993). A combination of
b-sympathomimetic and aminophyllin has been reported to be
ef®cient on the wheals and itching (Husz et al 1994). Other drugs
such as cyproheptadine, ketotifen, oral cromoglycate, H2-blockers,
and IFNa are not effective (MoÈller and Henz, 1998). In patients
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with CU who do not respond to the previous treatments, induction
of cold tolerance has been proposed. The patients must be
hospitalized and treated with antihistamines. Cold water is applied
several times daily on increasing body surface and with decreasing
temperature. The initial temperature of the cold water must be 5°C
above provocation. Risks of anaphylactic symptoms are always
present. Cold desensitization is dif®cult to carry out in daily life
over an extended period.
In conclusion, further investigations are needed for a better
understanding of the patho-physiologic mechanisms of CU and for
a better management of the patients.
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Table III. Infections and cold urticaria
NeittaanmaÈki (1985) 220 cases
Wanderer et al (1986)
Henquet et al (1992)
Husz et al (1994)
Koeppel et al (1996)
11 viral respiratory infections
10 streptococcal throat infections
4 bacterial pneumonias
3 sinusitis
3 rubellas
50 cases
1 infectious mononucleosis
30 cases
0 infection
42 cases
5 dental infections
104 cases
1 VIH infection
Table I. Idiopathic cold urticaria
NeittaanmaÈki (1985) 168/220 (31%)
Wanderer et al (1986)
Henquet et al (1992)
Husz et al (1994)
46/50 (92%)
26/30 (87%)
37/42 (88%)
Koeppel et al (1996) 99/104 (95%)
Table II. Cryoglobulinemia and cold urticaria
NeittaanmaÈki (1985) 2/220 (0.01%)
Wanderer et al (1986)
Henquet et al (1992)
Husz et al (1994)
2/50 (0.04%)
0/30 (0%)
0/42 (0%)
Koeppel et al (1996) 4/104 (0.04%)
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